These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 10908759)

  • 1. Perinatal death and tocolytic magnesium sulfate.
    Scudiero R; Khoshnood B; Pryde PG; Lee KS; Wall S; Mittendorf R
    Obstet Gynecol; 2000 Aug; 96(2):178-82. PubMed ID: 10908759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adverse maternal and neonatal outcome of prolonged course of magnesium sulfate tocolysis.
    Nassar AH; Sakhel K; Maarouf H; Naassan GR; Usta IM
    Acta Obstet Gynecol Scand; 2006; 85(9):1099-103. PubMed ID: 16929415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent indomethacin tocolysis is not associated with neonatal complications in preterm infants.
    Vermillion ST; Newman RB
    Am J Obstet Gynecol; 1999 Nov; 181(5 Pt 1):1083-6. PubMed ID: 10561622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Magnesium sulfate tocolysis and risk of neonatal death.
    Grether JK; Hoogstrate J; Selvin S; Nelson KB
    Am J Obstet Gynecol; 1998 Jan; 178(1 Pt 1):1-6. PubMed ID: 9465794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prenatal magnesium sulfate exposure and the risk for cerebral palsy or mental retardation among very low-birth-weight children aged 3 to 5 years.
    Schendel DE; Berg CJ; Yeargin-Allsopp M; Boyle CA; Decoufle P
    JAMA; 1996 Dec; 276(22):1805-10. PubMed ID: 8946900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tocolytic magnesium sulfate exposure and risk of cerebral palsy among children with birth weights less than 1,750 grams.
    Boyle CA; Yeargin-Allsopp M; Schendel DE; Holmgreen P; Oakley GP
    Am J Epidemiol; 2000 Jul; 152(2):120-4. PubMed ID: 10909948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. If tocolytic magnesium sulfate is associated with excess total pediatric mortality, what is its impact?
    Mittendorf R; Pryde P; Khoshnood B; Lee KS
    Obstet Gynecol; 1998 Aug; 92(2):308-11. PubMed ID: 9699773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antenatal exposure to magnesium sulfate and the incidence of patent ductus arteriosus in extremely low birth weight infants.
    del moral T; Gonzalez-Quintero VH; Claure N; Vanbuskirk S; Bancalari E
    J Perinatol; 2007 Mar; 27(3):154-7. PubMed ID: 17314984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intrapartum Magnesium Sulfate.
    Demasio KA
    Neoreviews; 2020 May; 21(5):e353-e360. PubMed ID: 32358150
    [No Abstract]   [Full Text] [Related]  

  • 10. Maternal magnesium therapy, neonatal serum magnesium concentration and immediate neonatal outcomes.
    Narasimhulu D; Brown A; Egbert NM; Rojas M; Haberman S; Bhutada A; Minkoff H; Rastogi S
    J Perinatol; 2017 Dec; 37(12):1297-1303. PubMed ID: 28981078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of magnesium sulfate on fetal heart rate patterns in the second stage of labor.
    Duffy CR; Odibo AO; Roehl KA; Macones GA; Cahill AG
    Obstet Gynecol; 2012 Jun; 119(6):1129-36. PubMed ID: 22617576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of magnesium sulfate on maternal and fetal platelet aggregation.
    Rhee E; Beiswenger T; Oguejiofor CE; James AH
    J Matern Fetal Neonatal Med; 2012 May; 25(5):478-83. PubMed ID: 21762000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Magnesium sulfate tocolysis and intraventricular hemorrhage in very preterm infants.
    Petrova A; Mehta R
    Indian J Pediatr; 2012 Jan; 79(1):43-7. PubMed ID: 21625843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of magnesium sulfate and nifedipine on the risk of developing pulmonary edema in preterm births.
    Xiao C; Gangal M; Abenhaim HA
    J Perinat Med; 2014 Sep; 42(5):585-9. PubMed ID: 24566358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antenatal risk factors associated with the development of lenticulostriate vasculopathy (LSV) in neonates.
    Mittendorf R; Kuban K; Pryde PG; Gianopoulos JG; Yousefzadeh D
    J Perinatol; 2005 Feb; 25(2):101-7. PubMed ID: 15496867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between the use of antenatal magnesium sulfate in preterm labor and adverse health outcomes in infants.
    Mittendorf R; Dambrosia J; Pryde PG; Lee KS; Gianopoulos JG; Besinger RE; Tomich PG
    Am J Obstet Gynecol; 2002 Jun; 186(6):1111-8. PubMed ID: 12066082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intrapartum magnesium sulfate is associated with neuroprotection in growth-restricted fetuses.
    Stockley EL; Ting JY; Kingdom JC; McDonald SD; Barrett JF; Synnes AR; Monterrosa L; Shah PS; ; ;
    Am J Obstet Gynecol; 2018 Dec; 219(6):606.e1-606.e8. PubMed ID: 30240651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term magnesium sulfate tocolysis and maternal osteoporosis in a triplet pregnancy: a case report.
    Levav AL; Chan L; Wapner RJ
    Am J Perinatol; 1998 Jan; 15(1):43-6. PubMed ID: 9475687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of maternal magnesium sulphate and ritodrine treatment on the neonate: a study with six-month follow-up.
    Rantonen T; Ekblad U; Grönlund J; Rikalainen H; Välimäki I; Kero P
    Acta Paediatr; 1999 Oct; 88(10):1142-6. PubMed ID: 10565464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Magnesium sulfate for the prevention of cerebral palsy.
    Mittendorf R; Pryde PG
    N Engl J Med; 2009 Jan; 360(2):189-90; author reply 190. PubMed ID: 19129535
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.